Filing Flows › Dianthus Therapeutics (DNTH) › Q4 2025 › vs Q4 2024
Dianthus Therapeutics (DNTH) Q4 2025 vs Q4 2024 (year over year)
Dianthus Therapeutics's revenue fell $1.0M (-79%) from $1.3M in Q4 2024 to $284K in Q4 2025.
Dianthus Therapeutics, Q4 2025: revenue $284K (-79% year over year), net loss $64.4M, operating cash flow −$47.0M. The chart draws each line against Q4 2024, the increases inside each band.
Every line
| Line | Q4 2025 | Q4 2024 | Change | % |
|---|---|---|---|---|
| Revenue | $284K | $1.3M | −$1.0M | -79% |
| Other income, net | $5.1M | $3.5M | $1.6M | +47% |
| Net loss | $64.4M | $28.4M | $36.0M | +127% |
| Costs & expenses | $69.8M | $33.2M | $36.6M | +110% |
| Operating costs | $69.8M | $33.2M | $36.6M | +110% |
| Research & development | $59.9M | $26.4M | $33.5M | +127% |
| General & admin | $9.9M | $6.8M | $3.1M | +45% |
| Operating cash sources | $64.4M | $28.4M | $36.0M | +127% |
| Depreciation | $27K | $26K | $1K | +4% |
| Share-based compensation | $6.0M | $3.9M | $2.1M | +53% |
| Working capital & other | $11.4M | −$2.9M | $14.4M | — |
| Cash used in operations | $47.0M | $27.4M | $19.5M | +71% |
| Net loss absorbed | $64.4M | $28.4M | $36.0M | +127% |
Questions
How much did Dianthus Therapeutics's revenue grow year over year in Q4 2025?
Dianthus Therapeutics's revenue fell $1.0M (-79%) from $1.3M in Q4 2024 to $284K in Q4 2025.